Latest filing published 18 Sept 2026 for PALVELLA THERAPEUTICS, INC., €220k. Read the official filing
This profile gathers the share dealings of Kathleen Goin in Palvella Therapeutics, Inc. The record holds 30 filings, for trades running from 19 November 2025 to 16 September 2026.
Every open-market trade on record is a sale: 17 sales worth €2.2M. Other entries cover 13 option exercises. So far in 2026, the count stands at no purchases and 17 sales.
Most recently, on 18 September 2026, the filings show an open-market sale worth €220k in Palvella Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations